Category: CURRENT TRIALS

Are you a teenager with moderate to severe atopic dermatitis?

Post author By admin
Post date June 2, 2023

Are you a teenager with moderate to severe atopic dermatitis?

Amgen is conducting a Phase 3, Randomized, 52-week, Placebo-controlled, Double-blind Study With Rerandomization to Assess the Efficacy, Safety, and Tolerability of XXXXXXXXXXX in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASTRO)

To participate in your local study, please contact (949) 844-0442 or fill out the form below.

Protocol #20210145

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Tags Atopic Dermatitis

CURRENT TRIALS TRIAL

Suffering from Moderate to Severe Hidradenitis Suppurativa?

Post author By admin
Post date January 20, 2023

Suffering from Moderate to Severe Hidradenitis Suppurativa?

Incyte is conducting a Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of XXXXXXXXX in Participants with Moderate to Severe Hidradenitis Suppurativa

To participate in your local study, please contact (949) 844-0442 or fill out the form below.

Protocol # INCB- 54707-301

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Tags Atopic Dermatitis

CURRENT TRIALS TRIAL

Previously Treated With Dupilumab for Atopic Dermatitis?

Post author By admin
Post date January 20, 2023

Eli Lilly is conducting an Open-Label Study of XXXXXXXXXX in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab.

To participate in your local study, please contact (949) 844-0442 or fill out the form below.

Protocol # J2T-MC-KGBO

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

27020 Alicia Parkway , Suite G
Laguna Niguel, CA 92677
Monday – Friday: 8AM – 5PM
Saturday and Sunday: Closed
(949) 707-5734
info@avancetrials.com

CURRENT TRIALS TRIAL

Suffering from Atopic Dermatitis?

Post author By admin
Post date July 25, 2022

Suffering from Atopic Dermatitis?

Eli Lilly and Company are conducting a Long-term Study to Assess the Safety and Efficacy of xxxxxxxxxxx in Patients With Moderate-to-Severe Atopic Dermatitis.

To participate in your local study, please contact (949) 844-0442 or fill out the form below.

Protocol # J2T-DM-KGAA/DRM06-AD07

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Tags Atopic Dermatitis, eczema

CURRENT TRIALS TRIAL

Hidradenitis Suppurativa Treatment Extension Study

Post author By admin
Post date November 1, 2021

Hidradenitis Suppurativa Treatment Extension Study

A Novartis multicenter, double-blind, randomized withdrawal extension study of subcutaneous XXXXXXXXXX to demonstrate long-term efficacy, safety and tolerability in subjects with moderate to severe hidradenitis suppurativa.

To participate in your local study, please contact (949) 844-0442 or fill out the form below.

Protocol # CAIN457M2301E1